Browse Guides  internal medicine  cardiology

Acute coronary syndrome

Prevalence
Clinical features
Differential diagnosis
Investigations
Therapy
Prevention
Prognosis
Therapy

Angioplasty

Offer angioplasty a to patients with single vessel disease. b  

Why?

  • Patients with non-acute coronary artery disease who have angioplasty compared with medical therapy have less angina  a and require less medication. a  
  • There is no clear effect on death or myocardial infarction. a
  • Patients who have angioplasty are more likely to require a CABG, but not clearly more likely to require further angioplasty. a

Angioplasty reduces angina but increases the risk of CABG compared with medical therapy

Patient a Treatment Comparison Outcome CER OR
(95% CI)
NNT
(95% CI)
non-acute coronary artery disease  angioplasty medical therapy angina
at 3 years
71% 0.70
(0.50 to 0.98)
13
(6 to 240)
  angioplasty medical therapy CABG
at 3 years
4.1% 1.59
(1.09 to 2.32)
-44
(-280 to -20)

Angioplasty reduces need for antianginal medication compared with medical therapy

Patient a Treatment Comparison Outcome CER RRR
(95% CI)
NNT
(95% CI)
coronary artery disease with >50% stenosis in at least 1 vessel  angioplasty +/- stent medical therapy on 1 or fewer anti-anginal drugs
at 3 years
47% -60%
(-90% to -35%)
4
(3 to 5)

 

Expiry date: June 2003
Levels of Evidence used in grading these guides

Authors   CM   Ball , N   Shenker
Reviewer   I K   Jang
CAT Writers   N   Shenker , CJ   Wotton , CM   Ball , RS   Phillips